MYC and cancer: This novel mechanism underscores the therapeutic potential of PF-3758309 in targeting RNA polymerase II dysregulation, particularly in transcriptionally addicted cancers like MYC-driven tumors that rely on heightened transcriptional output for sustained proliferation [29].